Skip to main content
User account menu
Log in
Search
Home
Data Sources
Studies
Institutions
Networks
What's new
Support
Home
EAU UroEvidenceHub (UEH)
First published
24/10/2025
Last updated
30/10/2025
Network
Download as PDF
Page content
Page content
Network identification
Network description
Network details
Contact
Institutions that are part of this network
Network identification
Network ID
1000000781
Network name and Acronym
EAU UroEvidenceHub (UEH)
Network website
https://www.uro-evidencehub.com/
Network countries
Denmark
Germany
Greece
Italy
Netherlands
Poland
Portugal
Spain
United Kingdom
ENCePP partner
No
Network description
The mission of the EAU UroEvidenceHub (UEH) is to improve patient care in urology by providing reliable insights from real-world clinical practice. The UEH is a federated network of real world data sources, dedicated to generating high-quality real-world evidence for urological conditions (onocological and non oncological).
Via the UEH Data Haven, the UEH connects multiple registries, observational cohorts, and data initiatives across the world, enabling collaborative research and supporting regulatory decision-making. The network is designed to store, integrate, and analyse data from diverse clinical settings while respecting privacy and data protection regulations. These are divided into projects, with the UEH currently housing and continuing several EU projects after the initial funding period has finished (e.g. PIONEER+ and PRAISE-U).
The network operates as a federated infrastructure. Data remain with the individual sources while standardized metadata and analytic tools allow for coordinated research and multi-center studies.
UEH is a collaborative ecosystem. It brings together academic institutions, healthcare providers, industry partners, and patient organisations. By harmonizing data standards and methods across member sources, the network ensures high-quality, reproducible evidence.
The platform began with prostate cancer via our projects PIONEER+ and ProReg (our prospective prostate cancer registry), and is now expanding to include screening images. In the future we will expand to more therapy areas, such as antimicrobial resistance and continence health.
Network details
Network primary therapeutic area:
Urinary tract disorders
Network funding:
EU institutional research programme
Non-for-profit organisation (e.g. charity)
Pharmaceutical company and other private sectorÂ
Contact
Ellen Moyse e.moyse@uroweb.org
Main
e.moyse@uroweb.org
Susan Evans Axelsson s.evansaxelsson@uroweb.org
Alternate
s.evansaxelsson@uroweb.org
Institutions that are part of this network
AstraZeneca
Erasmus Medical Centre Rotterdam
Novartis Pharmaceuticals
Helmholtz-Zentrum Dresden-Rossendorf, European Association of Urology
Data sources owned by the network
This Network does not have any data source registered in the catalogue
Studies conducted by the network
This Network does not have any Studies registered in the catalogue.
Share this page